INTRODUCTION
Type VI secretion systems have been reported to perform diverse functions, facilitating interactions both with eukaryotic hosts and with competing bacterial cells. With the availability of a large number of bacterial genome sequences, it has become clear that any given bacterial strain often contains more than one T6SS-encoding locus. This implies that the T6SS is a versatile secretion system potentially capable of facilitating a variety of diverse interactions with eukaryotes and/or with other bacteria (Jani and Cotter, 2010) . For example, Yersinia pestis and Burkholderia pseudomallei encode four and six T6SS loci, respectively (Bingle et al., 2008; Boyer et al., 2009 ). In the genome of P. aeruginosa, three T6SS loci have been identified: H1, H2, and H3-T6SS (Mougous et al., 2006) . T6SS effectors identified to date are encoded as either distinct open reading frames or as C-terminal domains of Valine-Glycine Repeat protein G (vgrG) genes. They have diverse activities including peptidoglycan hydrolases, nucleases, and phospholipases. The best-studied examples are Tse1-Tse3, which are H1-T6SS-dependent antibacterial toxin effectors. Tse1 and Tse3 have amidase and muramidase activity and act in the periplasm of target Gram-negative bacteria cells to degrade the peptidoglycan cell wall (Russell et al., 2011) . Tse2 is a cytoplasmic effector that acts as a potent inhibitor of target cell proliferation (Li et al., 2012) . And an Rhs (rearrangement hotspot) protein from Dickeya dadantii was shown to be exported by a T6S system, and its C-terminal domain carries nuclease activity which degrades target cell DNA (Koskiniemi et al., 2013) . P. aeruginosa also encodes three highly specific cognate immunity proteins, Tsi1-Tsi 3, which are tightly linked to the tse1-3 toxin genes and provide a self-resistance mechanism Russell et al., 2011) .
Phospholipase D (PLD) enzymes, which catalyze the hydrolysis of phosphodiester bonds, have been identified in viruses, bacteria, plants, fungi, and mammals (Selvy et al., 2011) . PLDs have been identified as bona fide virulence factors in various bacteria (Edwards and Apicella, 2006; Jacobs et al., 2010; Rudolph et al., 1999) . Recently, a superfamily of bacterial phospholipase/lipase enzymes has been identified as T6SS lipase effectors (Tle), which may be classified into five divergent families (termed Tle1-Tle5). One such effector is a PLD protein, PldA, which has been confirmed as a substrate for P. aeruginosa H2-T6SS and exhibits antibacterial activity (Russell et al., 2013) .
The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is crucial to a range of cellular processes including cell growth, proliferation, and programmed cell death (Krachler et al., 2011) . Akt phosphorylation has been shown to be required for cellular invasion by a number of bacterial pathogens (Goluszko et al., 2008; Kierbel et al., 2005) . During P. aeruginosa invasion of polarized epithelial cells, PI3K becomes activated and is recruited to the apical cell surface (Engel and Eran, 2011; Kierbel et al., 2007) . Recently, the H2-T6SS of P. aeruginosa was demonstrated to be involved in PI3K/Akt-dependent mammalian cell entry, although the relevant substrates involved in this pathway were not defined (Sana et al., 2012 ).
An intriguing class of T6SS-dependent exported substrates is represented by the VgrG proteins, which are often genetically or functionally linked with T6SS clusters. Initially VgrG proteins were considered to be only structural components of the T6SS secretion machinery although the identification of so-called ''evolved'' VgrG homologs has redefined their role also as secreted substrates. For example, in V. cholerae, an evolved VgrG-1 has been identified which has a C-terminal actin-crosslinking domain (Ma et al., 2009; Pukatzki et al., 2006) ; and VgrG-3 has a C-terminal domain that can hydrolyze the peptidoglycan cell wall of Gram-negative bacteria (Dong et al., 2013) .
The T6SS apparatus consists of a tube formed by Hcp proteins with VgrG proteins located at the tip. Both proteins have been shown to be involved in the secretion of T6SS effectors. It has been reported that the Tse2 effectors interact directly with the Hcp pore and translocate through the tube during secretion (Silverman et al., 2013) . In addition, the VgrG proteins, which contain C-terminal domains as effectors, can also bind other effectors during secretion by an as-yet-unknown mechanism (Dong et al., 2013) . Furthermore, proteins belonging to the proline-alanine-alanine-arginine (PAAR) repeat superfamily have been proposed to be involved in the attachment between effectors and the T6SS spike complex (Koskiniemi et al., 2013; Shneider et al., 2013) .
Understanding the virulence mechanisms of Pseudomonas is a high priority and timely, given that Multidrug-resistant P. aeruginosa was added to the CDC2013 threat report. While both H2 and H3-T6SSs have been implicated as important in mediating P. aeruginosa pathogenesis (Lesic et al., 2009) , no substrates for H3-T6SS have yet been established. Here, we report the identification and characterization of a H3-T6SS-dependent PLD effector, PldB (PA5089). We demonstrate that PldB contributes not only to interbacterial competitive fitness of P. aeruginosa but also to bacterial internalization into human epithelial cells. Furthermore, we demonstrate that the cell internalization process is facilitated by PLD-triggered PI3K/Akt pathway activation. Our findings lead us to propose that the widely distributed T6S PLD effectors are of importance to understanding the virulence of P. aeruginosa in addition to more generally informing on the evolution of specialized bacterial secretion systems.
RESULTS

PldB Is an H3-T6SS-Dependent Antibacterial Effector
Two PLD-like genes (pldA and pldB) are encoded in the genome of P. aeruginosa PAO1. PldA is demonstrated as an H2-T6SS-dependent antibacterial effector by degrading phosphatidylethanolamine (PE) (Russell et al., 2013) . However, the function of PldB is still unclear. Phylogenetic analyses based on two PLDconserved regions yielded a tree with four branches, with PldA and PldB being found in different clades ( Figure 1A and see Figure S1A online) . Indeed, PldA is closely related to eukaryotic Pld and phylogenetically distinct from PldB. This favors a previous hypothesis that the PldA of P. aeruginosa possibly has a eukaryotic origin (Wilderman et al., 2001) . Although PldA and PldB might share similar function as phospholipase D, the organizations of the dual HxKxxxxD catalytic motifs in the two proteins are distinct ( Figure 1B ). Since PldA exhibits antibacterial activity, we asked if PldB could also function as a bacterial toxin. Escherichia coli toxicity assays were performed to test this hypothesis. As a confirmed antibacterial effector that targets the cell membrane, PldA provided an ideal positive control for these assays. We noted that, when cytoplasmically expressed, both pldA and pldB show little toxic effect to E. coli ( Figures 1C, S1B , and S1D). However, when these PLD proteins were targeted to the bacterial periplasm using an artificial signal peptide, both PldA and PldB resulted in a high proportion of growth inhibition ( Figures 1D, S1C , and S1D). Previous observations showed that PldA's ability to hydrolyse phosphatidylcholine (PC) is dependent on a predicted catalytic histidine residue His 855 (Russell et al., 2013 ). Purified PldB was tested to determine whether it possesses similar enzymic features as PldA. PldA, PldB, and two PldB mutants (H305R and H642R) were expressed as N-terminal maltose binding protein (MBP) fusions with C-terminal hexahistidine tags. Both mutants showed decreased PLD activity compared to the wild-type (WT) PldA and PldB proteins ( Figure 1E) . Further, to test whether the two catalytic motifs of PldB contribute to its bacterial toxicity, membrane permeability was assayed for E. coli strains expressing (periplasmically) pldB, the two pldB mutants (H305R or H642R), or pldB with its cognate immunity genes. Our results demonstrated that mutation of either of the catalytic residues or coexpression with the immunity proteins decreased PldBdependent membrane permeability of E. coli ( Figure 1F ).
The H1 and H2-T6SSs of P. aeruginosa both facilitate their interbacterial toxic activities in a cell-cell contact manner (Russell et al., 2011 (Russell et al., , 2013 . Interestingly, while the H1-T6SS effectors are encoded by multiple P. aeruginosa strains, the H2-T6SS effector gene pldA appears to have been acquired by a more recent horizontal gene transfer event (Wilderman et al., 2001) . This is also true of the loci encoding pldB (Figure 2A ), suggesting that it may also be an H1-T6SS-independent substrate. Similar horizontal acquisition or genetic deletion events appear also to have occurred in many other strains for the Tle-family effectors (Figure S2 ). Quantitative RT-PCR analysis of P. aeruginosa PAO1 in the prolonged static culture at 37 C indicated that pldB expression is upregulated at the same time as the H3-T6SS locus ( Figure S3A ), further supporting the suggestion that it represents a substrate for H3-T6SS. Intra-and interbacterial growth competition assays were performed under these conditions, with several P. aeruginosa mutants and the T6SS target bacterium model, P. putida. First, we constructed mutant strains of clpV1-3, bearing deletion of the three ATPase genes vital for H1-3 T6SS functions, respectively. Intrabacterial competition assays between P. aeruginosa strains at 37 C for 48 hr showed that the ablation of H3-T6SS or PldB function, but not H1 or H2-T6SS, abolished bacterial toxicity, reducing the normal growth advantage ( Figure 2B ). Further, interbacterial competition assays between P. aeruginosa and P. putida confirmed that knocking out pldB also reduced the growth advantage to the same extent as the H3-T6SS clpV3 mutant under H3-T6SS-conducive conditions (37 C, 24 hr, Figure 2C ). Note that the growth advantage could be restored to either the pldB or clpV3 knockout strains by transcomplementation with a functional pldB or clpV3 gene, respectively. These results demonstrate that PldB is an effective H3-T6SS-dependent antibacterial toxin.
PldB is active in the bacterial periplasm, we speculated that its immunity protein(s) should encode N-terminal signal peptides. Interestingly, downstream of pldB, three open reading frames (ORFs), PA5088, PA5087, and PA5086, are homologs with high identity (more than 80%), with predicted signal peptides (Figure S4A ), suggesting that they are targeted to the periplasm ( Figure S4B ).
We tested whether PA5088, PA5087, and PA5086 encode immunity proteins for PldB. We constructed three expression plasmids which harbored the pldB gene alone and pldB with one (PA5088) or three (PA5088-PA5086) putative immunity protein genes for heterologous expression in the E. coli BL21 (DE3) pLysS strain. In all cases we translationally fused the pldB gene to a signal peptide to ensure targeting of the PldB protein into the periplasm. Figure 3A shows that the growth inhibition to the E. coli strain caused by the expression of pldB alone was decreased by an order of magnitude when it was coexpressed with PA5088. Coexpression of all three putative immunity proteins further decreased growth inhibition by another order of magnitude, indicating a dose-dependent additive protective effect of these immunity proteins.
To determine if the immunity proteins could physically interact with PldB, we performed coimmunoprecipitation studies using E. coli in which FLAG-tagged PldB was coexpressed with Myc-tagged immunity proteins. Western blot analysis confirmed that all three immunity proteins can specifically bind to PldB (Figure 3B) . Moreover, the immunity protein for PldA (PA3488) does not bind to PldB, and vice versa ( Figure S4C ). This indicates specificity of these immunity proteins for their cognate toxin effectors.
Growth competition assays were performed to verify if these three immunity proteins were able to rescue a fitness defect in a strain of P. aeruginosa in which the pldB and the immunity proteins had been deleted (DPA5089-DPA5086). Complementation of any of these three immunity proteins enabled the mutant strain to compensate for the growth disadvantage against the WT C. An empty vector was included as control. Ten-fold serial dilution of overnight culture was spotted onto LB medium plates from left to right.
(E) Phospholipase D activity assay. PLD activity of indicated proteins was determined by measuring the production of choline from phosphatidylcholine using the Amplex Red assay kit (Invitrogen) as described previously (Jacobs et al., 2010) . (F) Membrane permeability of E. coli strains expressing indicated proteins in pET22 b(+) after 2 hr induction as measured by P.I. staining. pldB-5086, pET22 expressing operon from PA5089 to PA5086. Unrelated P. aeruginosa cytosolic protein Vfr as negative control. a.u., arbitrary units. Error bars represent ± SEM (n = 3); **p < 0.05. See also Figure S1 .
P. aeruginosa ( Figure 3C ). Taken together, these results confirm that PA5088, PA5087, and PA5086 can all function as immunity proteins against PldB toxicity.
PLD Enzymic Activities of PldA and PldB Contribute to the Internalization of P. aeruginosa into Human Epithelial Cells
To address the potential role of PldB in P. aeruginosa internalization, we constructed several nonpolar mutant strains for testing bacterial invasion into adherent HeLa cells. It has been previously shown that H2-T6SS contributes to P. aeruginosa internalization into human epithelial cells during exponential phases (Sana et al., 2012 ). We therefore first tested a panel of singleloci mutants grown at this phase for their ability to be internalized into cultured cells. Although epithelial invasion of the mutant defective in H2-T6SS (DclpV2) decreased compared with WT strain as previously reported (Sana et al., 2012) , mutants defective in H1-T6SS (DclpV1), H3-T6SS (DclpV3), or pldB (DpldB) internalized at the same level as WT strain ( Figure 4A ), suggesting that they are not involved in the invasion by cells growing in exponential phase. Given that H3-T6SS and pldB are both coupregulated during stationary phase ( Figure S3B ), we tested single and double mutants grown at stationary phase. As the invasion efficiency of the H1-T6SS mutant (DclpV1) showed no difference to that of the WT at this phase ( Figure 4B ), it is clear that H1-T6SS is not involved in internalization. As single knockouts of either pldB, H2, or H3-T6SS showed no decrease in invasion efficiency ( Figure 4B ), we used DclpV2 as the parental strain to construct two double knockout strains (DclpV2&V3 and DpldB&V2). Importantly, the invasion efficiency of DpldB&V2 (a double knockout of the H2-T6SS function and the potential H3-T6SS effector-PldB) decreased significantly, which is similar to the result obtained using DclpV2&V3 (a double knockout of both the H2 and H3-T6SS functions) ( Figure 4B ). The complementation of the DpldB&V2 mutant with PldB restored the invasion phenotype ( Figure 4C ). 
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This implies that PldB secretion is dependent upon H3-T6SS and not H2-T6SS. Based on these findings and the previous competition assay results (Figures 2B and 2C) , we conclude that PldB is an H3-T6SS-dependent effector. In a similar manner we demonstrated that the DpldA&V3 (a double knockout of the H3-T6SS function and the H2-T6SS effector-PldA) showed a similar decrease in invasion efficiency when compared to the DclpV2&V3 mutant ( Figure 4B ), confirming that PldA is an H2-T6SS-dependent effector. We next tested whether the catalytic motifs of PldA and PldB, which play crucial roles in bacterial toxicity, are required for the cell invasion process. We noted the invasion efficiency of the DpldB&V2 mutant (which still retains a functional H3-T6SS) was restored to WT levels when complemented with WT PldB, but not with a version of PldB in which important catalytic residues had been mutated ( Figure 4C ). Equivalent results were seen with similar experiments using the DpldA&V3 mutant (which retains a functional H2-T6SS) complemented with either a WT or mutant pldA gene ( Figure 4C ). These findings imply that the PLD activities of PldA and PldB, both of which would generate phosphatidic acid (PA), are important in contributing to the P. aeruginosa invasion phenotype.
Cytotoxicity assays under the same conditions used for the HeLa cell invasion studies demonstrated that neither PldA nor PldB promoted any cytotoxicity ( Figure S5A ). Furthermore, bacterial adhesion and survival assays showed no difference between the WT and mutant strains ( Figures S5B and S5C) , supporting the suggestion of a specific function for PldA/B in cellular internalization.
Finally, we explored the invasion of P. aeruginosa strains into a more physiologically relevant cell line, human alveolar epithelial cells (A549). Similar bacterial invasion results were obtained as observed in the HeLa cell assays ( Figure 4D ). Based on these findings we conclude that PldA and PldB contribute to internalization in human epithelial cells in a PLD activity-dependent manner. 
Translocation of PLD-Bla Fusion Proteins into HeLa Cells
Translocation of PldA/B into HeLa cells was determined by using a TEM-1 b-lactamase fusion PLD (PLD-Bla) and CCF2-AM. CCF2-AM is a FRET substrate that can accumulate in host cells.
In the absence of b-lactamase it emits green fluorescence, while in the presence of b-lactamase it can be cleaved and produces blue fluorescence (Ma et al., 2009 ). Cells infected with PAO1 strain expressing the PldB-Bla protein displayed higher blue/ green fluorescence ratio than those infected with the WT strain, which lacks the TEM-1 fusion protein. However, incubation with the H3-T6SS mutant reduced the fluorescence ratio to a similar level to that of the WT strain. In a similar way we demonstrated that infection with a strain expressing PldA-Bla had a high fluorescence ratio, while incubation with the H2-T6SS mutant again displayed a lower ratio ( Figure 5A ). Fluorescence microscopy imaging illustrated that the cells became blue when exposed to strains containing PldA-Bla or PldB-Bla, but remained green with either of the H2/3-T6SS mutants ( Figure 5B ). This supports the cytosolic translocation of PldA and PldB are dependent on H2 or H3-T6SS, respectively.
PldA and PldB Activate the PI3K/Akt Pathway during P. aeruginosa Infection The eukaryotic PI3K/Akt signaling pathway has been shown to play an essential role in the epithelial cell invasion of P. aeruginosa (Kierbel et al., 2005) . The activation of PI3K and subsequent Akt phosphorylation has been demonstrated to be H2-T6SS dependent (Sana et al., 2012) . To test the role of PldB in this pathway, a PI3K-specific inhibitor, LY294002, was used to test the link between the PLD protein and the PI3K/ Akt pathway. Internalization assays demonstrated that the DclpV2 and DclpV3 mutants presented similar invasion efficiencies as the WT strain. As expected, the PI3K inhibitor LY294002 abolished epithelial invasion by either the WT strain or the PldB transcomplemented DpldB&V2 mutant strain in a dose-dependent manner ( Figure 6A ). These results suggested that PI3K/Akt pathway is required for the H3-T6SS-dependent internalization. Nevertheless, bacterial adhesion to monolayers was not affected by the LY294002 treatment (data not shown), indicating that the PI3K/Akt pathway has no role in this bacterial phenotype. To further verify whether PldA and PldB are involved in the process of PI3K/Akt activation, the status of Akt phosphorylation at serine 473 was determined by western blot. Cultured HeLa cells were infected with the PAO1 WT strain, and the double mutants: DclpV2&V3, DpldA&V3, and DpldB&V2. Cell lysates were then immunoblotted and probed for total and phosphorylated Akt, respectively. Phosphorylation of Akt was notably reduced in cells that had been infected with the DclpV2&V3, DpldA&V3, and DpldB&V2 mutants compared with the WT strain ( Figure 6B ). We note that the complemented mutant strains, DpldB&V2 with PldB and DpldA&V3 with PldA, restored Akt activation to the levels induced by the WT PAO1 ( Figure 6B ). These findings demonstrate that PldA and PldB are involved in the activation of PI3K/Akt signal pathway during P. aeruginosa invasion. 
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Previous work has indicated that the N. gonorrhoeae PLD can interact directly with Akt kinase (Edwards and Apicella, 2006) . We therefore tested if PldA and PldB could also bind to the Akt kinase, using a PLD-Akt pull-down assay. As anticipated, MBP fusions of both PldA and PldB were shown to bind Akt immune complexes ( Figure 6C ). As negative controls we confirmed that neither the MBP protein alone nor the unrelated P. aeruginosa T3SS phopholipase ExoU binds to Akt kinase ( Figures 6C and  S6A ). The binding of the PldA and PldB to Akt was confirmed by performing the converse experiments in which Akt could be detected in complex with MBP-PLD that had been isolated using anti-MBP conjugated magnetic beads ( Figure 6D ). To determine which specific Akt-kinase these effectors were binding to, we used three different antibodies with specificities to Akt1, Akt2, or Atk3. In these pull-down assays we were only able to detect the Akt1 and 2 proteins, implying that PldA and PldB could not bind to Akt3 ( Figure 6D ). Interestingly, pull-down assays with PldA and PldB inactivated mutants showed that PLD activity was not required for binding to Akt ( Figure S6B ). Moreover, coexpression of PldA or PldB with Akt1 directly in HeLa cells showed that they colocalized close to the plasma membrane ( Figure 6E ), and that neither PldA nor PldB exhibited any cytotoxicity to eukaryotic cell when expressed directly in HeLa ( Figures S6C  and S6D ). These results suggest that a PLD-Akt complex forms during the P. aeruginosa infection.
DISCUSSION
Bacterial secretion systems can specifically recognize and release a distinct subset of substrates to the cell surface, the extracellular milieu, or directly translocate proteins into host cells (Galá n, 2009; Izoré et al., 2011) . For example, P. aeruginosa T3SS translocates a specific phospholipase effector, ExoU, which exhibits toxicity in the host cell (Dean, 2011) . For the H1-T6SS of P. aeruginosa, several effectors have been shown to be bacteriolytic enzymes that degrade the peptidoglycan of adjacent prokaryotic cells Russell et al., 2011) . Here, we present the identification of a P. aeruginosa H3-T6SS-dependent trans-kingdom effector, PldB. While PldA, a eukaryotic-like PLD antibacterial protein, was previously shown to be secreted via the H2-T6SS (Russell et al., 2013) , we demonstrate here its additional role in eukaryotic cell invasion. This is of particular importance to understanding the virulence of P. aeruginosa as we show PLD activity is pivotal for not only antibacterial toxicity but also the ability to invade human epithelial cells. It is likely that the same T6SS-elaborated intercellular channel or bridge that is used to translocate effectors into adjacent bacterial cells (Basler et al., 2012) is also used to translocate the PLD effectors into eukaryotic cells.
A common feature of T6SS antibacterial effectors is the tight linkage of immunity protein genes which confer self-immunity. An alignment of the three confirmed PldB immunity proteins shows they are close homologs, possible generated through gene duplication ( Figure S4A ). All three homologs appear to function equally well in protecting against PldB toxicity, and contribute to resistance in a dose-dependent manner, suggesting a comparable blocking mechanism. Considering that many other pldB homologous loci also encode more than one immunity protein ( Figure S4D ), it remains possible that ''stockpiling'' a range of immunity proteins may serve to protect against similar effector proteins from related species, which would otherwise pose a threat. It is interesting to note the clear role of PldB in growth competition, under conditions which are different from that of H2-T6SS-dependent PldA secretion (prolonged incubation at 37 C for PldB and SCFM media 23 C for PldA). P. aeruginosa is known to colonize the lungs of cystic fibrosis (CF) patients in stagnant mucus secretions which are depleted in oxygen (Worlitzsch et al., 2002) . Previous transcriptome analyses have indicated that pldB and H3-T6SS loci are both upregulated under low-oxygen conditions (Alvarez-Ortega and Harwood, 2007) and also during biofilm formation (Dö tsch et al., 2012) . Induction of PldB and H3-T6SS in these conditions may allow better colonization of the lung epithelium through invasion. Furthermore, given that P. aeruginosa is found within polyclonal and polymicrobial biofilms in the lung (Sibley et al., 2006; Singh et al., 2000) , we may speculate that PldB also provides a competitive advantage in the harsh environment of a long-term CF infection.
The Hcp and VgrG proteins have both been shown to play a role in the export of T6SS effectors (Basler et al., 2012; Shneider et al., 2013) . Recently, Hcp1 in P. aeruginosa PAO1 has been reported as a chaperone and receptor for the H1-T6SS secretion of 
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Tse2, where the effector interacts with the inner surface of Hcp1 rings (Silverman et al., 2013) . Hcp forms homohexameric rings which stack to form tubular structures (4 nm in diameter) with VgrG localized at the tip (Basler et al., 2012) . It is predicted that PldA (122.3 kDa) and PldB (83.4 kDa) proteins would be too large to be transported through the Hcp tube unless they are in an unfolded state or have an elongated conformation. An alternative mechanism has been proposed in which effector transport does not require transit through the Hcp tube (Shneider et al., 2013) . Five hcp and ten vgrG genes are encoded in the genome of P. aeruginosa PAO1 (Barret et al., 2011) , and our coimmunoprecipitation and bacterial two-hybrid assays support this hypothesis in that although neither PldA nor PldB bind to any of the Hcp proteins ( Figure S7 ), they can directly interact with VgrG proteins. Unfortunately, little binding specificity was observed (Figure S7 ), potentially due to the interference of in vitro buffer conditions to noncovalent binding between these proteins. It is still possible that the precise T6SS substrate selection mechanism is more complex than the straightforward Hcp/VgrG-substrate interactions we have tested here. Indeed, in Agrobacterium tumefaciens Hcp interacts directly with VgrG-1 (Lin et al., 2013) .
PI3K/Akt activation is a common mechanism that intracellular pathogens use to invade host cells. During the intracellular invasion processes of Listeria monocytogenes (Sidhu et al., 2005) and Helicobacter pylori (Allen et al., 2005) , PI3K is activated specifically at the site of bacterial aggregation on the cell surface for Akt phosphorylation. A similar phenomenon has been observed in P. aeruginosa invasion (Kierbel et al., 2007) , suggesting an analogous mechanism for cellular entry of this pathogen. Unlike the observation in N. gonorrhoeae, which demonstrated that NgPLD augments epithelial invasion by interacting with Akt kinase in a PI3K-independent manner and competes with a natural Akt ligand, Ptdlns(3,4,5)P 3 (phosphatidylinositol 3,4,5-trisphosphate), for Akt binding, our findings showed that PLDinduced cell invasion in P. aeruginosa is PI3K dependent and that its activity is critical for the cell invasion process, as mutants in the conserved catalytic motifs cannot complement the invasion defects in the knockout strain. Also, this PLD activity is not related to Akt binding. This is consistent with findings that implicate phosphatidic acid, a product of PLD activity degrading the major components of cellular membrane PC ( Figure 1E ) or PE (Russell et al., 2013) , in the positive regulation of Akt phosphorylation (Toschi et al., 2009) .
Since PLD from other bacteria can bind Akt and facilitate its translocation to membrane ruffles where it becomes phosphorylated (Edwards and Apicella, 2006) , we may speculate that the interaction of PldA/B-Akt could induce a similar effect. Moreover, our results demonstrated that PldA/B can interact with Akt1 and Akt2, but not Akt3. Akt1/2 has been proven to play a role in the regulation of palladin activity, which modulates actin cytoskeletal organization Toker, 2010a, 2010b) . As protrusion formation following actin rearrangement was considered to benefit bacterial entry of epithelial cells (Engel and Eran, 2011) , we therefore proposed a model in which PLD-induced Akt activation results in actin rearrangement and membrane protrusion on the apical surface which facilitates P. aeruginosa internalization (Figure 7) . Although the detailed mechanism of PLD-dependent Akt activation remains unclear, our demonstration of the involvement of H2/3-T6SS secreted substrates is important for understanding how P. aeruginosa gains entry into epithelial cells.
The H2/3-T6SS loci have been shown to be essential P. aeruginosa mammalian virulence factors (Lesic et al., 2009) . In this study we have unraveled the importance of the two H2/ 3-T6SS-dependent PLD effectors, PldA and PldB, in the process of the killing of bacterial competitors and for internalization into human epithelial cells. The lack of homology between PldA and PldB suggests they have developed similar functions by convergent evolution. This would suggest a highly selected trait and critical role for their activities regarding virulence and sur- vival of the bacterium in the mammalian host. Interestingly, TseL, which is a V. cholerae T6SS lipase effector, was also shown to be required for killing D. discoideum amoebae (Dong et al., 2013) . As type VI lipase effectors are widely distributed in diverse bacterial pathogens, including Vibrio, Burkholderia, and Pseudomonas, their interactions with a range of different eukaryotic cells may be expected. Finally, these PLD-like effectors may also represent exciting targets for antimicrobial drug development for combating chronic infections such as those in CF patients.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Growth Conditions, and Plasmids All bacterial strains and plasmids used in this study are listed in Table S1 . Details of growth conditions and strain and plasmid constructions are described in Supplemental Experimental Procedures.
E. coli Toxicity and Membrane Permeability Assays
Overnight cultures of E. coli strain BL21 (DE3) pLysS containing pET28 a(+) or pET22 b(+) expressing cytoplasmic or periplasmic targeted proteins were serially diluted in LB medium at 10-fold. A total of 5 ml of this bacterial dilution was spotted on LB agar containing 0.25 mM IPTG. Pictures were taken after 16-24 hr growth. E. coli strains harboring pET22 b(+) derivatives encoding both effector and immunity proteins were performed in a similar way. For membrane permeability assay, overnight cultures were diluted and pregrown for 2 hr, and then induced with 0.1 mM IPTG for 2 hr. Cells were stained with 1.5 mM propidium iodide (P.I.) in PBS for 15 min, and fluorescence was measured at 535/617 nm (excitation/emission). Data were normalized to the cell density as measured by OD 600 .
Growth Competition Assays
Intra-and interspecies competition assays were conducted as described in Supplemental Experimental Procedures. For P. aeruginosa-P. putida competition, the initial donor-recipient ratio was 1:1 (OD 600 of 3.0 for each strain) and incubation for 24 hr at 37 C (a condition shown to induce transcriptional co-upregulation of H3-T6SS and pldB, P. putida harbored pBBR1MCS5 for gentamycin selection). For P. aeruginosa-P. aeruginosa competition, the initial ratio was 5:1 (OD 600 of 1.0 for donor strain and OD 600 of 0.2 for recipient strain) and incubation for 48 hr at 37 C (a condition shown to induce transcriptional co-upregulation of H3-T6SS and pldB).
Coimmunoprecipitation and Western Blot Analysis FLAG-tagged PLD proteins in pME6032 and Myc-tagged Hcps, VgrGs, or immunity proteins in pBAD/Myc-His A were coexpressed in E. coli. Cell lysates were incubated with 50 ml anti-FLAG or anti-Myc magnetic beads (MBL) at 4 C for 2 hr. Beads were washed three times with Tris-buffered saline (TBS), and bound proteins (IP) were eluted for western blot analysis. Full details are in Supplemental Experimental Procedures.
PLD Protein Purification and Phospholipase D Activity Assay
PldA, PldB, and its mutants were fused with 3 0 His tag and purified using nickel affinity chromatography (Amersham). For full details of purification, see Supplemental Experimental Procedures. Purified PLD protein was used at 400 nM for the Phospholipase D activity assay at 37 C for 2 hr by using the Amplex Red assay kit (Invitrogen). All measured fluorescent values were normalized against a buffer-only control.
Cell Invasion Assays
HeLa or A549 cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM, Thermo Scientific) supplemented with 10% fetal bovine serum (FBS) and streptomycin-penicillin (Invitrogen) as needed in 12-well plates. Cell cultures were grown to 70% confluence at 37 C (under 5% CO 2 ) before washing with sterile PBS. After infection with P. aeruginosa (WT or mutant strains) from either exponential (OD 600 0.5-0.8) or stationary phase (OD 600 3.0-4.0) at a multiplicity of infection (moi) of 50 (if needed, 0.1 mM IPTG was added for induction), the tissue culture plates were centrifuged for 5 min at 1,000 g. Following a 3 hr infection the cells were washed twice with PBS before incubation in DMEM containing 200 mg/ml gentamycin at 37 C for 2 hr. Finally, the cells were washed with PBS three times before lysis with ddH 2 O containing 0.1% Triton X-100 on ice for 30 min. After serial dilution, colony-forming units (CFUs) were counted to determine the number of internalized bacteria in the epithelial cells. Inhibitor experiments were carried out as above except that cells were preincubated with DMEM containing LY294002 (Cell Signaling Technology, CST) for 1 hr.
Translocation Assay for PLD::TEM-1 Fusions HeLa cells were grown in 96-well plates to 70% confluence as described above. After two washes with PBS the cells were infected with bacterial strains expressing TEM-1 fusion PLDs (at a moi of 100) for 3 hr. Host cells were then washed with HBSS and treated with CCF2-AM (Invitrogen) for 90 min at room temperature. Fluorescence was quantified using a microtiter plate reader at an excitation of 405 nm according to the manufacturer's instructions. Translocation was demonstrated as a ratio of cleaved (460 nm, blue) to uncleaved (530 nm, green) signal. For microscopic observation, samples were examined with a Nikon fluorescence microscope.
Statistical Analysis
Two sample t test comparisons were used to confirm statistical significance at 95% confidence between the two samples compared; *p < 0.01 and **p < 0.05.
Akt Immunoblotting and Pull-Down Assay
HeLa cells grown in 6-well plates were infected with stationary phase bacteria for 1 hr at a moi of 100 at 37 C. The epithelial cells were washed with cold PBS twice and then lysed with 300 ml RIPA buffer (CST) supplemented with protease and phosphatase inhibitor cocktail (Roche) on ice for 30 min. After that, cells were scraped off and centrifuged at 14,000 rpm for 15 min. The supernatant was collected and the protein concentration was determined by Bradford reagent (Sigma). Approximately 40 mg lysate was boiled in SDS-PAGE loading buffer, and western blot was performed. For Akt-PLD pull-down assay, HeLa cell crude lysate and purified PLD or MBP (New England Biolabs) proteins were mixed and incubated with anti-MBP magnetic beads (New England Biolabs) or Akt mouse mAb (magnetic bead conjugate, CST) at 4 C for 2 hr. Similar procedures as described in coimmunoprecipitation were conducted to detect Akt or PLD proteins in the immune complexes.
Microscopy
Microscopy observation followed the standard protocols. Full details are in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one 
